DK140500C - - Google Patents

Info

Publication number
DK140500C
DK140500C DK381572A DK381572A DK140500C DK 140500 C DK140500 C DK 140500C DK 381572 A DK381572 A DK 381572A DK 381572 A DK381572 A DK 381572A DK 140500 C DK140500 C DK 140500C
Authority
DK
Denmark
Application number
DK381572A
Other languages
Danish (da)
Other versions
DK140500B (da
Inventor
V Zikan
M Semonsky
K Rezabek
M Auskova
M Seda
Original Assignee
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS568971A external-priority patent/CS152153B1/cs
Priority claimed from CS570971A external-priority patent/CS156178B1/cs
Application filed by Spofa Spojene Podniky Pro Zdravotnickou Vyrobu filed Critical Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Publication of DK140500B publication Critical patent/DK140500B/da
Application granted granted Critical
Publication of DK140500C publication Critical patent/DK140500C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK381572AA 1971-08-05 1972-08-02 Analogifremgangsmåde til fremstilling af N-(D-6-methyl-8-isoergolin-I-yl)-N',N'-diethylurinstof og salte heraf. DK140500B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS568971A CS152153B1 (nl) 1971-08-05 1971-08-05
CS570971A CS156178B1 (nl) 1971-08-05 1971-08-05

Publications (2)

Publication Number Publication Date
DK140500B DK140500B (da) 1979-09-17
DK140500C true DK140500C (nl) 1980-02-11

Family

ID=25746228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK381572AA DK140500B (da) 1971-08-05 1972-08-02 Analogifremgangsmåde til fremstilling af N-(D-6-methyl-8-isoergolin-I-yl)-N',N'-diethylurinstof og salte heraf.

Country Status (12)

Country Link
US (1) US3953454A (nl)
JP (1) JPS5247480B2 (nl)
BE (1) BE787036A (nl)
CA (1) CA976958A (nl)
CH (2) CH573936A5 (nl)
DE (1) DE2238540C3 (nl)
DK (1) DK140500B (nl)
FI (1) FI53127C (nl)
FR (1) FR2150746B1 (nl)
GB (1) GB1358358A (nl)
NL (1) NL174550C (nl)
SE (1) SE374111B (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS522798A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
JPS522799A (en) * 1975-06-24 1977-01-10 Fuji Electric Co Ltd Control system for automatic sales machine
US4096266A (en) * 1976-04-06 1978-06-20 Hzi Research Center Lisuride in alcoholism
EP0021206B1 (de) * 1979-06-13 1983-06-22 Schering Aktiengesellschaft Neue (Ergolin-yl)-N', N'-diäthylharnstoff-Derivate, ihre Herstellung und sie enthaltende Arzneimittel
JPS5660173U (nl) * 1979-10-09 1981-05-22
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3129714A1 (de) * 1981-07-23 1983-02-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Anti-psychotikum
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3413660A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 2-(trialkyl-silyl)-ergolinderivaten
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10043321B4 (de) 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
WO2014092006A1 (ja) * 2012-12-10 2014-06-19 キッセイ薬品工業株式会社 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270020A (en) * 1966-08-30 Dihydro ergocornine
US3251846A (en) * 1966-05-17 G-dimethyosoergolenyl-b
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
GB1053507A (nl) * 1964-04-14
US3681497A (en) * 1966-06-07 1972-08-01 Spofa Vereinigte Pharma Werke Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide

Also Published As

Publication number Publication date
JPS4826799A (nl) 1973-04-09
JPS5247480B2 (nl) 1977-12-02
NL174550C (nl) 1984-07-02
SE374111B (nl) 1975-02-24
NL7210812A (nl) 1973-02-07
FI53127C (nl) 1978-02-10
DE2238540A1 (de) 1973-02-22
FR2150746A1 (nl) 1973-04-13
DE2238540C3 (de) 1978-05-24
FI53127B (nl) 1977-10-31
DE2238540B2 (de) 1977-09-29
FR2150746B1 (nl) 1976-07-02
GB1358358A (en) 1974-07-03
CH573937A5 (nl) 1976-03-31
US3953454A (en) 1976-04-27
NL174550B (nl) 1984-02-01
DK140500B (da) 1979-09-17
CA976958A (en) 1975-10-28
CH573936A5 (nl) 1976-03-31
BE787036A (fr) 1972-12-01

Similar Documents

Publication Publication Date Title
FR2150746B1 (nl)
AU2658571A (nl)
AU2691671A (nl)
AU2952271A (nl)
AU2941471A (nl)
AU2742671A (nl)
AU2564071A (nl)
AU2684071A (nl)
AU3005371A (nl)
AU2485671A (nl)
AU2894671A (nl)
AU2740271A (nl)
AU2654071A (nl)
AU2875571A (nl)
AU2854371A (nl)
AU2837671A (nl)
AU2836771A (nl)
AU2755871A (nl)
AU2885171A (nl)
AU2907471A (nl)
AU2726271A (nl)
AU2724971A (nl)
AU2706571A (nl)
AU2927871A (nl)
AU2684171A (nl)

Legal Events

Date Code Title Description
PBP Patent lapsed